Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients

Advances in DNA sequencing have made genetic testing fast and affordable, but limitations of testing processes are impeding realisation of patient benefits. Ovarian cancer exemplifies the potential value of genetic testing and the shortcomings of current pathways to access testing. Approximately 15%...

תיאור מלא

מידע ביבליוגרפי
Main Authors: George, A, Riddell, D, Seal, S, Talukdar, S, Mahamdallie, S, Ruark, E, Cloke, V, Slade, I, Kemp, Z, Gore, M, Strydom, A, Banerjee, S, Hanson, H, Rahman, N
פורמט: Journal article
שפה:English
יצא לאור: Nature Research 2016

פריטים דומים

פריטים דומים